Cargando…
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
SIMPLE SUMMARY: Despite recent advances in treatment, metastasized prostate carcinoma (PC) still has a poor prognosis. Immunotherapy has revolutionized the landscape of cancer therapy, but a breakthrough for PC is missing. The success of immunotherapy in cancers is mostly due to recent strategies to...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867165/ https://www.ncbi.nlm.nih.gov/pubmed/33535627 http://dx.doi.org/10.3390/cancers13030549 |